Cargando…
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
Patients with multiple myeloma (MM) are typically of an advanced age and may have significant co-existing medical conditions. They have often had multiple lines of therapy and as such experience disease-related effects alongside associated treatment toxicities. Daratumumab is a monoclonal antibody a...
Autores principales: | King, Tracy, Jagger, Jacqueline, Wood, Jodie, Woodrow, Carmel, Snowden, Alicia, Haines, Sally, Crosbie, Christina, Houdyk, Kristen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996585/ https://www.ncbi.nlm.nih.gov/pubmed/29963589 http://dx.doi.org/10.4103/apjon.apjon_9_18 |
Ejemplares similares
-
International expert opinion on the use of nebulization for pediatric asthma therapy during the COVID-19 pandemic
por: Shen, Kunling, et al.
Publicado: (2021) -
Daratumumab for the Treatment of Multiple Myeloma
por: Plesner, Torben, et al.
Publicado: (2018) -
Home blood pressure monitoring: Australian Expert Consensus Statement
por: Sharman, James E., et al.
Publicado: (2015) -
Daratumumab in dialysis-dependent multiple myeloma
por: Jeyaraman, Preethi, et al.
Publicado: (2020) -
Daratumumab efficacy in extramedullary orbital myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2020)